| Primary |
| Growth Of Eyelashes |
63.7% |
| Product Used For Unknown Indication |
11.3% |
| Hypotrichosis |
10.4% |
| Drug Use For Unknown Indication |
4.0% |
| Madarosis |
2.3% |
| Dry Eye |
2.1% |
| Hypothyroidism |
1.1% |
| Hypertension |
0.7% |
| Skin Wrinkling |
0.7% |
| Hormone Replacement Therapy |
0.5% |
| Eyelash Thickening |
0.5% |
| Hair Growth Abnormal |
0.5% |
| Eyelash Discolouration |
0.4% |
| Depression |
0.3% |
| Hypercholesterolaemia |
0.3% |
| Seasonal Allergy |
0.3% |
| Pain |
0.3% |
| Menopause |
0.2% |
| Acne |
0.2% |
| Blood Cholesterol Increased |
0.2% |
|
| Ocular Hyperaemia |
15.9% |
| Madarosis |
15.8% |
| Drug Ineffective |
12.5% |
| Skin Hyperpigmentation |
7.4% |
| Wrong Technique In Drug Usage Process |
6.7% |
| Erythema Of Eyelid |
5.2% |
| Trichorrhexis |
4.6% |
| Eyelids Pruritus |
4.4% |
| Eye Pruritus |
3.9% |
| Eye Irritation |
3.4% |
| Therapeutic Response Decreased |
3.2% |
| Eyelid Oedema |
3.1% |
| Vision Blurred |
3.0% |
| Skin Discolouration |
2.4% |
| Hair Growth Abnormal |
1.8% |
| Incorrect Dose Administered |
1.5% |
| Erythema |
1.4% |
| Scleral Hyperaemia |
1.4% |
| Eye Swelling |
1.3% |
| Inappropriate Schedule Of Drug Administration |
1.2% |
|
| Secondary |
| Growth Of Eyelashes |
51.2% |
| Hypotrichosis |
14.5% |
| Dry Eye |
5.7% |
| Product Used For Unknown Indication |
4.5% |
| Madarosis |
4.3% |
| Eyelash Discolouration |
2.7% |
| Skin Wrinkling |
2.5% |
| Eyelash Thickening |
2.4% |
| Hair Growth Abnormal |
1.6% |
| Drug Use For Unknown Indication |
1.4% |
| Eye Disorder |
1.2% |
| Hypertension |
1.2% |
| Seasonal Allergy |
1.2% |
| Breast Cancer |
1.0% |
| Hormone Replacement Therapy |
1.0% |
| Menopause |
1.0% |
| Accidental Exposure |
0.8% |
| Chemotherapy |
0.8% |
| Erythema |
0.6% |
| Hypercholesterolaemia |
0.6% |
|
| Madarosis |
19.9% |
| Wrong Technique In Drug Usage Process |
15.9% |
| Drug Ineffective |
12.0% |
| Ocular Hyperaemia |
8.0% |
| Trichorrhexis |
8.0% |
| Hair Growth Abnormal |
4.3% |
| Inappropriate Schedule Of Drug Administration |
4.0% |
| Skin Hyperpigmentation |
3.6% |
| Erythema Of Eyelid |
2.9% |
| Eyelids Pruritus |
2.9% |
| Incorrect Dose Administered |
2.5% |
| Therapeutic Response Decreased |
2.5% |
| Eye Pruritus |
2.2% |
| Scleral Hyperaemia |
2.2% |
| Vision Blurred |
1.8% |
| Drug Administered At Inappropriate Site |
1.4% |
| Drug Interaction |
1.4% |
| Erythema |
1.4% |
| Eye Swelling |
1.4% |
| Eyelid Oedema |
1.4% |
|
| Concomitant |
| Skin Wrinkling |
35.7% |
| Osteoporosis |
14.3% |
| Product Used For Unknown Indication |
14.3% |
| Anxiety |
7.1% |
| Drug Use For Unknown Indication |
7.1% |
| Growth Of Eyelashes |
7.1% |
| Skin Cosmetic Procedure |
7.1% |
| Sleep Disorder |
7.1% |
|
| Madarosis |
22.2% |
| Vision Blurred |
22.2% |
| Adverse Event |
11.1% |
| Dry Eye |
11.1% |
| Facial Paresis |
11.1% |
| Keratitis |
11.1% |
| Wrong Technique In Drug Usage Process |
11.1% |
|
